Application 761100

Type
BLA
Sponsor
SAMSUNG BIOEPIS CO LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ONTRUZANTTRASTUZUMAB-DTTBINJECTABLE;INJECTION150MGNoNo
002ONTRUZANTTRASTUZUMAB-DTTBPOWDER;IV (INFUSION)420MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0006-5033OntruzanttrastuzumabMerck Sharp & Dohme Corp.BLACurrent
0006-5033OntruzanttrastuzumabMerck Sharp & Dohme Corp.BLACurrent
0006-5034OntruzantOntruzantMerck Sharp & Dohme Corp.BLACurrent
0006-5034OntruzantOntruzantMerck Sharp & Dohme Corp.BLACurrent
78206-147OntruzanttrastuzumabOrganon LLCBLACurrent
78206-148OntruzantOntruzantOrganon LLCBLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84370SUPPL 2025-12-09
81493SUPPL 2025-03-07
81444SUPPL 2025-03-07
70106SUPPL2022-02-07
70103SUPPL2022-02-07
57314ORIG2019-03-07
57908ORIG2019-03-05
57246ORIG2019-01-18